These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32672464)

  • 1. Amplified Detection of Breast Cancer Autoantibodies Using MUC1-Based Tn Antigen Mimics.
    Guillen-Poza PA; Sánchez-Fernández EM; Artigas G; García Fernández JM; Hinou H; Ortiz Mellet C; Nishimura SI; Garcia-Martin F
    J Med Chem; 2020 Aug; 63(15):8524-8533. PubMed ID: 32672464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
    Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
    Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.
    Wandall HH; Blixt O; Tarp MA; Pedersen JW; Bennett EP; Mandel U; Ragupathi G; Livingston PO; Hollingsworth MA; Taylor-Papadimitriou J; Burchell J; Clausen H
    Cancer Res; 2010 Feb; 70(4):1306-13. PubMed ID: 20124478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1 glycopeptide epitopes predicted by computational glycomics.
    Song W; Delyria ES; Chen J; Huang W; Lee JS; Mittendorf EA; Ibrahim N; Radvanyi LG; Li Y; Lu H; Xu H; Shi Y; Wang LX; Ross JA; Rodrigues SP; Almeida IC; Yang X; Qu J; Schocker NS; Michael K; Zhou D
    Int J Oncol; 2012 Dec; 41(6):1977-84. PubMed ID: 23023583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tn Antigen Mimics Based on sp(2)-Iminosugars with Affinity for an anti-MUC1 Antibody.
    Fernández EM; Navo CD; Martínez-Sáez N; Gonçalves-Pereira R; Somovilla VJ; Avenoza A; Busto JH; Bernardes GJ; Jiménez-Osés G; Corzana F; Fernández JM; Mellet CO; Peregrina JM
    Org Lett; 2016 Aug; 18(15):3890-3. PubMed ID: 27453399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
    Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
    J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody.
    Martínez-Sáez N; Castro-López J; Valero-González J; Madariaga D; Compañón I; Somovilla VJ; Salvadó M; Asensio JL; Jiménez-Barbero J; Avenoza A; Busto JH; Bernardes GJ; Peregrina JM; Hurtado-Guerrero R; Corzana F
    Angew Chem Int Ed Engl; 2015 Aug; 54(34):9830-4. PubMed ID: 26118689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
    Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
    Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.
    Ryan SO; Vlad AM; Islam K; Gariépy J; Finn OJ
    Biol Chem; 2009 Jul; 390(7):611-8. PubMed ID: 19426130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
    Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
    Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Synthetic MUC1 Glycopeptide Bearing βGalNAc-Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells.
    Leiria Campo V; Riul TB; Oliveira Bortot L; Martins-Teixeira MB; Fiori Marchiori M; Iaccarino E; Ruvo M; Dias-Baruffi M; Carvalho I
    Chembiochem; 2017 Mar; 18(6):527-538. PubMed ID: 28068458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope.
    Singh J; Her C; Supekar N; Boons GJ; Krishnan VV; Brooks CL
    J Pept Sci; 2020 Jan; 26(1):e3229. PubMed ID: 31729101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.
    Kagan E; Ragupathi G; Yi SS; Reis CA; Gildersleeve J; Kahne D; Clausen H; Danishefsky SJ; Livingston PO
    Cancer Immunol Immunother; 2005 May; 54(5):424-30. PubMed ID: 15625606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.
    Burford B; Gentry-Maharaj A; Graham R; Allen D; Pedersen JW; Nudelman AS; Blixt O; Fourkala EO; Bueti D; Dawnay A; Ford J; Desai R; David L; Trinder P; Acres B; Schwientek T; Gammerman A; Reis CA; Silva L; Osório H; Hallett R; Wandall HH; Mandel U; Hollingsworth MA; Jacobs I; Fentiman I; Clausen H; Taylor-Papadimitriou J; Menon U; Burchell JM
    Br J Cancer; 2013 May; 108(10):2045-55. PubMed ID: 23652307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.
    Napoletano C; Rughetti A; Agervig Tarp MP; Coleman J; Bennett EP; Picco G; Sale P; Denda-Nagai K; Irimura T; Mandel U; Clausen H; Frati L; Taylor-Papadimitriou J; Burchell J; Nuti M
    Cancer Res; 2007 Sep; 67(17):8358-67. PubMed ID: 17804752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.
    Sarkar S; Salyer AC; Wall KA; Sucheck SJ
    Bioconjug Chem; 2013 Mar; 24(3):363-75. PubMed ID: 23444835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.
    Gabba A; Attariya R; Behren S; Pett C; van der Horst JC; Yurugi H; Yu J; Urschbach M; Sabin J; Birrane G; Schmitt E; van Vliet SJ; Besenius P; Westerlind U; Murphy PV
    J Am Chem Soc; 2023 Jun; 145(24):13027-13037. PubMed ID: 37279388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor-associated glycopeptides by lectins: the peptide context modulates carbohydrate recognition.
    Madariaga D; Martínez-Sáez N; Somovilla VJ; Coelho H; Valero-González J; Castro-López J; Asensio JL; Jiménez-Barbero J; Busto JH; Avenoza A; Marcelo F; Hurtado-Guerrero R; Corzana F; Peregrina JM
    ACS Chem Biol; 2015 Mar; 10(3):747-56. PubMed ID: 25457745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.